Concepedia

Ri‐Yao Yang

RY

32

Publications

3.9K

Citations

25

H-Index

1996

Active since

Affiliations

University of California, Davis(Current)

Institute of Biomedical Sciences, Academia Sinica

La Jolla Institute for Immunology

The University of Texas MD Anderson Cancer Center

China Medical University

Ri‐Yao Yang is an author at University of California, Davis specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

1996–2023

32

Publications

32

Expression of galectin-3 modulates T-cell growth and apoptosis.

Ri‐Yao Yang, Daniel K. Hsu, F T Liu · Proceedings of the National Academy of Sciences · 1996 · 780 citations · Full text

, , +9

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy

Ri‐Yao Yang, Linlin Sun, Ching-Fei Li et al. · Nature Communications · 2021 · 561 citations · Full text

Targeted Disruption of the Galectin-3 Gene Results in Attenuated Peritoneal Inflammatory Responses

Daniel K. Hsu, Ri‐Yao Yang, Zhixing K. Pan et al. · American Journal Of Pathology · 2000 · 428 citations · Full text

, , +10

Galectin-7 (PIG1) Exhibits Pro-apoptotic Function through JNK Activation and Mitochondrial Cytochrome cRelease

Ichiro Kuwabara, Yasuko Kuwabara, Ri‐Yao Yang et al. · Journal of Biological Chemistry · 2002 · 199 citations · Full text

Galectin-3 negatively regulates TCR-mediated CD4<sup>+</sup>T-cell activation at the immunological synapse

Huan‐Yuan Chen, Agnes Fermin, Santosha A. Vardhana et al. · Proceedings of the National Academy of Sciences · 2009 · 189 citations · Full text

Rows per page

1–5 of 32